Earnings Summary

Amgen Inc.’s revenue jumped 5.94% since last year same period to $6986Mn in the Q2 2023. On a quarterly growth basis, Amgen Inc. has generated 14.43% jump in its revenue since last 3-months.

Amgen Inc.’s net profit jumped 4.71% since last year same period to $1379Mn in the Q2 2023. On a quarterly growth basis, Amgen Inc. has generated -51.46% fall in its net profits since last 3-months.

Amgen Inc.’s net profit margin fell -1.17% since last year same period to 19.74% in the Q2 2023. On a quarterly growth basis, Amgen Inc. has generated -57.58% fall in its net profit margins since last 3-months.

Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 4.08 - a -8.11% fall from last quarter’s estimates.

Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 4.08.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amgen Inc.’s return on assets (ROA) stands at 0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amgen Inc.’s return on equity (ROE) stands at 1.73.

Amgen Inc. declared 2.13 dividend per share during the earnings announcement for Q1 2023.